Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Companion Animal Diagnostic Services Market, by Type
1.4.2 North America Companion Animal Diagnostic Services Market, by Animal Type
1.4.3 North America Companion Animal Diagnostic Services Market, by Testing Category
1.4.4 North America Companion Animal Diagnostic Services Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2022, Sep – 2023, Aug) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. North America Companion Animal Diagnostic Services Market by Type
5.1 North America Point-of-Care (POC) Market by Country
5.2 North America Laboratory-based Market by Country
Chapter 6. North America Companion Animal Diagnostic Services Market by Animal Type
6.1 North America Dogs Market by Country
6.2 North America Cats Market by Country
6.3 North America Horses Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Companion Animal Diagnostic Services Market by Testing Category
7.1 North America Clinical Chemistry Market by Country
7.2 North America Microbiology Market by Country
7.3 North America Parasitology Market by Country
7.4 North America Histopathology Market by Country
7.5 North America Cytopathology Market by Country
7.6 North America Hematology Market by Country
7.7 North America Immunology & Serology Market by Country
7.8 North America Imaging Market by Country
7.9 North America Molecular Diagnostics Market by Country
7.1 North America Others Market by Country
Chapter 8. North America Companion Animal Diagnostic Services Market by Country
8.1 US Companion Animal Diagnostic Services Market
8.1.1 US Companion Animal Diagnostic Services Market by Type
8.1.2 US Companion Animal Diagnostic Services Market by Animal Type
8.1.3 US Companion Animal Diagnostic Services Market by Testing Category
8.2 Canada Companion Animal Diagnostic Services Market
8.2.1 Canada Companion Animal Diagnostic Services Market by Type
8.2.2 Canada Companion Animal Diagnostic Services Market by Animal Type
8.2.3 Canada Companion Animal Diagnostic Services Market by Testing Category
8.3 Mexico Companion Animal Diagnostic Services Market
8.3.1 Mexico Companion Animal Diagnostic Services Market by Type
8.3.2 Mexico Companion Animal Diagnostic Services Market by Animal Type
8.3.3 Mexico Companion Animal Diagnostic Services Market by Testing Category
8.4 Rest of North America Companion Animal Diagnostic Services Market
8.4.1 Rest of North America Companion Animal Diagnostic Services Market by Type
8.4.2 Rest of North America Companion Animal Diagnostic Services Market by Animal Type
8.4.3 Rest of North America Companion Animal Diagnostic Services Market by Testing Category
Chapter 9. Company Profiles
9.1 Zoetis, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 IDEXX Laboratories, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.2.6 SWOT Analysis
9.3 Mars, Inc.
9.3.1 Company Overview
9.3.2 Recent strategies and developments:
9.3.2.1 Acquisition and Mergers:
9.3.3 SWOT Analysis
9.4 Fujifilm Holdings Corporation
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Acquisition and Mergers:
9.4.6 SWOT Analysis
9.5 Embark Veterinary, Inc.
9.5.1 Company Overview
9.5.2 SWOT Analysis
9.6 Thermo Fisher Scientific, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.6 SWOT Analysis
9.7 Patterson Companies, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 SWOT Analysis
9.8 Randox Laboratories Limited
9.8.1 Company Overview
9.8.2 SWOT Analysis
9.9 CVS Group plc
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Analysis
9.9.4 Recent strategies and developments:
9.9.4.1 Partnerships, Collaborations, and Agreements:
9.9.5 SWOT Analysis
9.10. Neogen Corporation
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Product Launches and Product Expansions:
9.10.5.2 Acquisition and Mergers:
9.10.6 SWOT Analysis
Unique Offerings 